IHC assay was used to detect the expression levels of CD59, NF-κB (p65), and the phosphorylation levels of p65 and CREB in 26 paired DLBCL patients before and after at least 6 cycles of R-CHOP treatment. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.